Aster Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Aster Capital Management's PCVX Position: Q3 2026 in Review
Aster Capital Management opened a new position in Vaxcyte (PCVX) in Q3 2026: 106 shares worth $6.03K. The stake represents ﹤0.01% of the portfolio and ranks #823 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in PCVX as recently as Q1 2026.
Aster Capital Management first reported a position in PCVX in Q3 2024 and has held it in 4 quarters since. The position peaked at $477K in Q3 2024. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Aster Capital Management held 106 shares of Vaxcyte worth $6.03K as of Q3 2026.
- Vaxcyte was a new Aster Capital Management position in Q3 2026.
- Vaxcyte made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #823 holding.
- Aster Capital Management first reported a position in Vaxcyte in Q3 2024 and has held it in 4 quarters since.
- Aster Capital Management's Vaxcyte position peaked at $477K in Q3 2024.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.